Mainz Biomed N.V. Ordinary Shares
Symbol: MYNZ (NASDAQ)
1.62
▲ (1.89%) 0.030
Company Description:
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
Key Stats
- Today's Open: $1.62
- Today's High: $1.62
- Today's Low: $1.62
- Today's Volume: 527
- Yesterday Close: $1.59
- Yesterday High: $1.64
- Yesterday Low: $1.55
- Yesterday Volume: 124.02K
- Last Min Volume: 502
- Last Min High: $1.62
- Last Min Low: $1.62
- Last Min VWAP: $1.62
Company Profile
- Name: Mainz Biomed N.V. Ordinary Shares
- Website: https://www.mainzbiomed.com
- Listed Date: 2021-11-05
- Location: ,
- Market Status: Active
- CIK Number: 0001874252
- SIC Code:
- SIC description:
- Market Cap: $8.61M
- Round Lot: 100
- Outstanding Shares: 5.41M
- Asset Type: CS
RECENT FILINGS FOR MYNZ
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-03 | 6-K | View |
| 2025-10-03 | 424B5 | View |
| 2025-10-03 | 424B3 | View |
| 2025-09-26 | 6-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-05 | 6-K | View |
| 2025-08-05 | 424B3 | View |
| 2025-08-04 | EFFECT | View |
| 2025-07-31 | CORRESP | View |
| 2025-07-31 | CORRESP | View |
| 2025-07-30 | F-1 | View |
| 2025-07-18 | UPLOAD | View |
| 2025-07-15 | DRS | View |
| 2025-06-05 | 6-K | View |
| 2025-05-21 | 424B3 | View |
| 2025-05-21 | 6-K | View |
| 2025-05-16 | EFFECT | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-14 | F-1/A | View |
| 2025-05-14 | CORRESP | View |
Latest News on MYNZ